Philips et al., 2021 - Google Patents
Critical updates on chronic hepatitis B virus infection in 2021Philips et al., 2021
View HTML- Document ID
- 14440420745762666298
- Author
- Philips C
- Ahamed R
- Abduljaleel J
- Rajesh S
- Augustine P
- Publication year
- Publication venue
- Cureus
External Links
Snippet
Chronic hepatitis B virus (HBV) infection is a global healthcare burden in the form of chronic liver disease, cirrhosis, liver failure and liver cancer. There is no definite cure for the virus and even though extensive vaccination programs have reduced the burden of liver disease …
- 208000000419 Chronic Hepatitis B 0 title abstract description 42
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Philips et al. | Critical updates on chronic hepatitis B virus infection in 2021 | |
| Dusheiko et al. | New approaches to chronic hepatitis B | |
| Suk‐Fong Lok | Hepatitis B treatment: what we know now and what remains to be researched | |
| You et al. | Guidelines for the prevention and treatment of chronic hepatitis B (version 2022) | |
| Ringehan et al. | Viral hepatitis and liver cancer | |
| Liu et al. | Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways | |
| Xiang et al. | Identification of cholesterol 25-hydroxylase as a novel host restriction factor and a part of the primary innate immune responses against hepatitis C virus infection | |
| Konerman et al. | Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers | |
| Chuang et al. | Pathogenicity and virulence of Hepatitis B virus | |
| Jiang et al. | Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate | |
| Jiang et al. | Toll‐like receptor‐mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen | |
| Feuillet et al. | Combining antivirals and immunomodulators to fight COVID-19 | |
| Kaneko et al. | A novel tricyclic polyketide, vanitaracin A, specifically inhibits the entry of hepatitis B and D viruses by targeting sodium taurocholate cotransporting polypeptide | |
| Deng et al. | Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway | |
| Amako et al. | Role of oxysterol binding protein in hepatitis C virus infection | |
| Li et al. | Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment | |
| Pascarella et al. | Hepatitis D virus: an update | |
| Jiang et al. | Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles | |
| Sanada et al. | Transmission of HBV DNA mediated by ceramide-triggered extracellular vesicles | |
| Weng et al. | Elevation of plasma soluble human leukocyte antigen–G in patients with chronic hepatitis C virus infection | |
| Tian et al. | Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection | |
| Cai et al. | The multiple functions of B cells in chronic HBV infection | |
| Wang et al. | Hepatitis B e antigen inhibits NF-κB activity by interrupting K63-linked ubiquitination of NEMO | |
| Li et al. | Hepatitis C virus vaccine development: old challenges and new opportunities | |
| Shi et al. | Inhibition of hepatitis C virus production by aptamers against the core protein |